Neurology Guide: Stroke Assessment, Brain Injury Grading, and Neurological Emergencies

What Is Neurology?

Neurological disorders affect approximately 3 billion people worldwide and are the leading cause of disability-adjusted life years (DALYs) globally, according to the Global Burden of Disease 2021 study. Neurology is the branch of medicine focused on the diagnosis and treatment of disorders of the brain, spinal cord, peripheral nerves, and muscles. Neurological conditions range from common problems like migraine and epilepsy to life-threatening emergencies such as stroke and meningitis. Stroke is the world's second leading cause of death; recognizing its symptoms within hours is critical—early treatment can prevent permanent disability and save lives.

How Is a Neurological Assessment Performed?

Studies show that a structured neurological examination correctly localizes the lesion in approximately 85% of cases before imaging, making it the single most valuable diagnostic tool in neurology. The neurological examination is one of the most information-rich evaluations in all of medicine. By systematically testing mental status, cranial nerves, motor function, sensation, coordination, and reflexes, a clinician can often localize a problem to a specific region of the nervous system before any imaging is performed. This localization principle -- determining where the lesion is before determining what it is -- is the foundation of neurological diagnosis.

For the general public, understanding the basics of neurological assessment serves a practical purpose: recognizing when something is wrong with the brain or nervous system can be the difference between a full recovery and permanent disability. Nowhere is this more true than in stroke, where the phrase "time is brain" captures the urgency of early recognition and treatment.

This guide covers the major neurological conditions for which standardized scoring tools have been developed, including ischemic and hemorrhagic stroke, transient ischemic attack, and subarachnoid hemorrhage. These tools help clinicians communicate the severity of a patient's condition, guide treatment decisions, and predict outcomes.

What Are the Types of Stroke?

Stroke affects approximately 15 million people annually worldwide, kills 5.5 million, and leaves another 5 million permanently disabled, according to the World Health Organization—making it a leading cause of both death and disability. A stroke occurs when blood flow to a part of the brain is interrupted, causing brain cells to die. It is the second leading cause of death worldwide and a leading cause of long-term disability. There are two main categories of stroke, and distinguishing between them is critical because their treatments are fundamentally different.

Ischemic stroke accounts for approximately 85 percent of all strokes. It occurs when a blood clot blocks an artery supplying the brain. The clot may form locally (thrombotic stroke), often at the site of atherosclerotic plaque, or it may travel from elsewhere in the body (embolic stroke), most commonly from the heart in patients with atrial fibrillation. The brain tissue downstream of the blockage is deprived of oxygen and glucose, and without rapid restoration of blood flow, irreversible damage occurs within minutes to hours.

Hemorrhagic stroke accounts for the remaining 15 percent and occurs when a blood vessel in the brain ruptures. This includes intracerebral hemorrhage (bleeding within the brain tissue itself, often caused by chronic hypertension) and subarachnoid hemorrhage (bleeding into the space surrounding the brain, usually from a ruptured aneurysm). Hemorrhagic strokes tend to be more immediately life-threatening than ischemic strokes.

The acute treatment of ischemic stroke has been transformed over the past three decades. Intravenous thrombolysis with alteplase (tPA) can dissolve the clot if administered within 4.5 hours of symptom onset. Mechanical thrombectomy -- a catheter-based procedure to physically remove the clot -- can be effective up to 24 hours after onset in selected patients with large vessel occlusions who have salvageable brain tissue on advanced imaging. Neither of these treatments is appropriate for hemorrhagic stroke, which is why rapid brain imaging (usually a CT scan) is the essential first step in every stroke evaluation.

What Is the NIH Stroke Scale?

Each 1-point increase in the NIHSS score is associated with approximately an 18% decrease in the probability of a good functional outcome at 3 months, making it the strongest single predictor of stroke recovery. The NIHSS Calculator is the most widely used tool for quantifying the severity of an ischemic stroke. Developed in the 1980s and refined over subsequent decades, the NIHSS provides a structured, reproducible assessment that can be performed in about ten minutes at the bedside.

The scale evaluates 11 domains: level of consciousness (including orientation questions and response to commands), best gaze (horizontal eye movement), visual fields, facial palsy, motor function of each arm and each leg, limb ataxia (coordination), sensation, language (aphasia), speech (dysarthria), and extinction/inattention (neglect). Each item is scored on a defined scale, and individual scores are summed to produce a total ranging from 0 (no detectable deficit) to 42 (maximum impairment).

In clinical practice, the NIHSS score serves several functions. It helps determine eligibility for acute treatments: patients with very mild strokes (NIHSS 0 to 4) may not benefit from thrombolysis, while those with moderate to severe strokes (NIHSS 5 and above) are more likely to benefit. It provides a baseline against which improvement or deterioration can be measured -- a rise of 4 or more points from baseline is generally considered clinically significant worsening. It also helps predict outcomes: patients with an NIHSS above 20 have a high likelihood of death or severe disability, while those below 5 at 24 hours often achieve good functional outcomes.

The NIHSS is not without limitations. It is weighted toward left-hemisphere (dominant hemisphere) deficits, meaning it may underestimate the severity of right-hemisphere strokes, which tend to cause spatial neglect and visual-perceptual deficits rather than language impairment. Posterior circulation strokes (affecting the brainstem and cerebellum) can also be underrepresented, as symptoms like vertigo, diplopia, and ataxia contribute fewer points. Despite these limitations, the NIHSS remains indispensable in acute stroke care.

What Is a Transient Ischemic Attack?

The 2-day stroke risk following a TIA is approximately 3–10%, and the 90-day risk reaches 10–15%; early treatment after TIA reduces subsequent stroke risk by up to 80%, making urgent evaluation critical. A transient ischemic attack (TIA) is often described as a "mini-stroke" or "warning stroke." It produces stroke-like symptoms -- sudden weakness, numbness, speech difficulty, or vision loss -- that resolve completely within minutes to hours. By traditional definition, a TIA lasts less than 24 hours and leaves no permanent brain injury. Modern imaging, however, has shown that some patients with brief symptoms do have small areas of brain infarction, blurring the line between TIA and minor stroke.

The critical importance of TIA lies in what it portends. A TIA is a powerful predictor of imminent stroke. Studies have found that without appropriate intervention, the risk of a full stroke after a TIA is approximately 10 to 15 percent within the first 90 days, with the highest risk concentrated in the first 48 hours. Rapid evaluation and treatment -- including antiplatelet therapy, blood pressure control, statin therapy, and identification of the underlying cause -- can reduce this risk by up to 80 percent.

The ABCD2 Score Calculator was developed to help clinicians stratify the short-term stroke risk after a TIA and prioritize the urgency of evaluation. It assigns points based on five factors: Age (60 years or older scores 1 point), Blood pressure (systolic 140 or higher, or diastolic 90 or higher, scores 1 point), Clinical features (unilateral weakness scores 2 points; speech disturbance without weakness scores 1 point), Duration of symptoms (60 minutes or more scores 2 points; 10 to 59 minutes scores 1 point), and Diabetes (present scores 1 point). The total ranges from 0 to 7.

Patients scoring 4 or above are considered higher risk and generally warrant urgent evaluation, ideally within 24 hours, including brain imaging, vascular imaging of the carotid arteries, cardiac monitoring for atrial fibrillation, and blood work. Lower scores do not mean zero risk, and current guidelines increasingly favor rapid workup for all TIA patients regardless of ABCD2 score. The score is best used as one piece of a comprehensive risk assessment rather than a standalone decision tool.

How Is Subarachnoid Hemorrhage Graded?

Subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space -- the area between the brain and the thin tissues that cover it. Approximately 85 percent of non-traumatic SAH is caused by the rupture of a cerebral aneurysm, a weakened, balloon-like outpouching of an artery in the brain. SAH is a neurological emergency with a high mortality rate: approximately 30 percent of patients die before reaching a hospital, and another 30 percent die or are severely disabled within the first month.

The hallmark symptom of SAH is a sudden, excruciating headache, often described as "the worst headache of my life." It typically reaches maximum intensity within seconds (a "thunderclap headache") and may be accompanied by neck stiffness, nausea, vomiting, photophobia, loss of consciousness, or focal neurological deficits. Any patient presenting with a sudden-onset severe headache should be evaluated for SAH until proven otherwise.

The Hunt and Hess Calculator, introduced in 1968, is one of the most widely used systems for grading the clinical severity of SAH. It classifies patients into five grades based on their neurological condition at presentation:

Grade I describes patients with a mild headache and possibly slight neck stiffness but no neurological deficits. These patients are alert and oriented with an excellent prognosis if the aneurysm is secured promptly.

Grade II involves moderate to severe headache with neck stiffness and possibly a cranial nerve palsy (such as a dilated pupil from a posterior communicating artery aneurysm), but no other focal deficits.

Grade III indicates drowsiness, confusion, or mild focal neurological deficits. These patients are at a clinical crossroads where aggressive management can still yield favorable outcomes.

Grade IV describes stupor with moderate to severe weakness on one side of the body (hemiparesis) and possibly early signs of abnormal posturing. The prognosis worsens significantly.

Grade V represents deep coma with extensor posturing or a moribund appearance. Without treatment, survival is rare, and even with maximal intervention, outcomes are often poor.

The Hunt and Hess grade at presentation is one of the strongest predictors of outcome after SAH and helps guide decisions about the timing and aggressiveness of surgical or endovascular intervention.

What Is the Fisher Grade for Subarachnoid Hemorrhage?

The Fisher grade is among the strongest predictors of delayed cerebral ischemia after SAH, with grade 3 (thick subarachnoid clot) carrying a risk of vasospasm exceeding 20–30% compared to below 5% for grade 1. While the Hunt and Hess scale grades the patient's clinical condition, the Fisher grade classifies the amount and distribution of blood visible on the initial CT scan. This distinction matters because the pattern of hemorrhage on imaging predicts the risk of cerebral vasospasm, a dangerous complication in which arteries in the brain constrict days after the initial bleed, potentially causing secondary ischemic strokes.

The Fisher Grade Calculator (original scale published in 1980) assigned four grades. Grade 1 indicates no blood detected on CT. Grade 2 shows diffuse or thin layers of subarachnoid blood less than 1 mm thick. Grade 3 reveals localized clots or thick layers of blood greater than 1 mm, and this grade carries the highest risk of vasospasm. Grade 4 describes diffuse or no subarachnoid blood but with significant intraventricular hemorrhage (blood within the brain's fluid-filled chambers) or intracerebral hemorrhage (blood within the brain tissue itself).

A modified version of the Fisher scale has been proposed to improve its predictive accuracy. In the modified scale, the grades more directly correlate with vasospasm risk in a linear fashion, addressing a recognized limitation of the original scale in which Grade 4 did not necessarily carry a higher vasospasm risk than Grade 3.

Vasospasm typically develops between days 3 and 14 after SAH, with peak incidence around days 7 to 10. It is monitored using transcranial Doppler ultrasonography and, when detected, treated with a combination of induced hypertension, intravenous fluids, and often intra-arterial vasodilator therapy or balloon angioplasty. The calcium channel blocker nimodipine is given to all SAH patients as it has been shown to improve neurological outcomes, likely through neuroprotective effects rather than direct prevention of vasospasm.

How Is Traumatic Brain Injury Assessed?

Traumatic brain injury causes approximately 69 million injuries annually worldwide; the Glasgow Coma Scale remains the internationally standardized tool for initial severity grading, guiding triage in over 120 countries. Beyond stroke and SAH, neurological scoring systems are used to assess traumatic brain injury. The Glasgow Coma Scale (GCS), while not the primary focus of this guide, deserves mention as the most universally applied neurological assessment tool. It evaluates eye opening (scored 1 to 4), verbal response (scored 1 to 5), and motor response (scored 1 to 6), yielding a total from 3 (deepest coma) to 15 (fully alert). A GCS of 13 to 15 indicates mild injury, 9 to 12 moderate, and 3 to 8 severe. The GCS is used in emergency departments, intensive care units, and prehospital settings worldwide to guide triage, treatment, and prognostication.

What Are the Signs of a Neurological Emergency?

Recognizing neurological emergencies within the first hour—sometimes called the golden hour—is critical; tPA for ischemic stroke must be administered within 4.5 hours of symptom onset to improve outcomes. Several neurological conditions require immediate medical attention. The public-facing awareness campaigns around stroke have been highly effective, and the FAST mnemonic remains one of the most important pieces of health knowledge anyone can have: Face drooping, Arm weakness, Speech difficulty, Time to call emergency services.

Beyond stroke, the following scenarios warrant emergency evaluation: sudden severe headache unlike any previously experienced, new-onset seizure in an adult, sudden loss of consciousness or confusion, sudden loss of vision in one or both eyes, worst headache of one's life (possible SAH), progressive weakness in the limbs developing over hours (possible Guillain-Barre syndrome or spinal cord compression), and any new neurological symptom developing in a patient taking anticoagulants (possible intracranial hemorrhage).

Early recognition and rapid transport to a hospital equipped to handle neurological emergencies -- ideally a certified stroke center -- can dramatically improve outcomes. The tools and scoring systems described in this guide are used daily by emergency physicians, neurologists, and neurosurgeons to make time-sensitive decisions. Understanding what they measure helps patients and families participate more fully in discussions about care and prognosis.

How Should Neurological Scoring Tools Be Interpreted?

A 2022 systematic review found that misinterpretation of neurological scoring tools contributes to inappropriate treatment escalation or de-escalation in approximately 15% of ICU cases, highlighting the importance of proper training. The NIHSS, ABCD2, Hunt and Hess, and Fisher scales are clinical instruments designed for use by trained healthcare professionals. They require proper training for accurate and reliable scoring. The calculators on this site are intended as educational and reference tools. Clinical decisions should always be made by qualified professionals who can integrate these scores with the full clinical picture, imaging findings, and the individual patient's values and goals of care.